Edition:
United Kingdom

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

199.49USD
22 Oct 2018
Change (% chg)

$-0.70 (-0.35%)
Prev Close
$200.19
Open
$200.19
Day's High
$201.35
Day's Low
$199.01
Volume
250,816
Avg. Vol
457,161
52-wk High
$206.63
52-wk Low
$159.23

Select another date:

Wed, Oct 10 2018

Photo

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

CVS, Aetna win U.S. approval for $69 billion deal

WASHINGTON/NEW YORK Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc , the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers. | Video

UPDATE 3-CVS, Aetna win U.S. approval for $69 bln deal

WASHINGTON/NEW YORK, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination with potential to cut U.S. healthcare costs for consumers.

CVS, Aetna win approval for merger

WASHINGTON, Oct 10 Pharmacy chain CVS Health Corp won U.S. antitrust approval for its $69 billion acquisition of health insurer Aetna Inc, the Justice Department said on Wednesday, paving the way for a combination the companies say can help cut soaring U.S. healthcare costs.

U.S. Justice Dept expected to approve CVS deal for Aetna as soon as Wed - source

WASHINGTON, Oct 10 The U.S. Justice Department is expected to approve drug retailer CVS Health Corp's deal to buy health insurer Aetna Inc as soon as Wednesday, a source familiar with the review said.

Aetna, seeking antitrust nod, sells Medicare drug business to WellCare

Health insurer Aetna Inc said on Thursday it will sell its standalone Medicare prescription drug plan business to WellCare Health Plans Inc as it seeks U.S. antitrust approval for a planned acquisition by CVS Health Corp .

UPDATE 3-Aetna, seeking antitrust nod, sells Medicare drug business to WellCare

Sept 27 Health insurer Aetna Inc said on Thursday it will sell its standalone Medicare prescription drug plan business to WellCare Health Plans Inc as it seeks U.S. antitrust approval for a planned acquisition by CVS Health Corp.

Aetna to sell one of its prescription plan units to WellCare

Sept 27 Health insurer Aetna Inc said on Thursday it would sell its Medicare Part D prescription drug plan business to WellCare Health Plans Inc to obtain U.S. approval for its planned $69 billion deal to merge with CVS Health Corp.

Cigna deal gets antitrust nod, positive sign for CVS-Aetna

Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing them to proceed with a combination they say will lead to lower costs by better coordinating pharmacy and medical benefits.

U.S. review of CVS deal for Aetna may end soon: source

WASHINGTON The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.

Select another date: